We first tested the genotype distribution of the CDK12 c.1047-2A>G splice site variant in the Hannover-Ufa Breast Cancer Study using genomic DNA samples from breast cancer cases and controls selected for Tatar ancestry where it had been originally described (6). The gene discussed is CDK12; the disease is breast carcinoma.